Zvada, S. P., Denti, P., Donald, P. R., Schaaf, H. S., Thee, S., Seddon, J. a., Seifart, H. I., Smith, P. J., McIlleron, H. M., & Simonsson, U. S. H. (2014). Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: In silico evaluation of currently recommended doses. Journal of Antimicrobial Chemotherapy, 69(5), 1339–1349. https://doi.org/10.1093/jac/dkt524
Denti, P., Sharp, S.-K., Kröger, W. L., Schwager, S. L., Mahajan, A., Njoroge, M., Gibhard, L., Smit, I., Chibale, K., Wiesner, L., Sturrock, E. D., & Davies, N. H. (2014). Pharmacokinetic evaluation of lisinopril-tryptophan, a novel C-domain ACE inhibitor. European Journal of Pharmaceutical Sciences, 56, 113–119. https://doi.org/10.1016/j.ejps.2014.01.012
Zvada, S. P., Denti, P., Sirgel, F. a, Chigutsa, E., Hatherill, M., Charalambous, S., Mungofa, S., Wiesner, L., Simonsson, U. S. H., Jindani, A., Harrison, T., & McIlleron, H. M. (2014). Moxifloxacin population pharmacokinetics and model-based comparison of efficacy between moxifloxacin and ofloxacin in African patients. Antimicrobial Agents and Chemotherapy, 58(1), 503–510. https://doi.org/10.1128/AAC.01478-13
Jeremiah, K., Denti, P., Chigutsa, E., Faurholt-Jepsen, D., PrayGod, G., Range, N., Castel, S., Wiesner, L., Hagen, C. M., Christiansen, M., Changalucha, J., McIlleron, H., Friis, H., & Andersen, A. B. (2014). Nutritional supplementation increases rifampicin exposure among tuberculosis patients co-infected with HIV. Antimicrobial Agents and Chemotherapy, 58(April), 3468–3474. https://doi.org/10.1128/AAC.02307-13
Zvada, S. P., Denti, P., Donald, P. R., Schaaf, H. S., Thee, S., Seddon, J. a., Seifart, H. I., Smith, P. J., McIlleron, H. M., & Simonsson, U. S. H. (2014). Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: In silico evaluation of currently recommended doses. Journal of Antimicrobial Chemotherapy, 69(5), 1339–1349. https://doi.org/10.1093/jac/dkt524